Atlantic Economic Journal

, Volume 43, Issue 3, pp 363–374 | Cite as

Longitudinal Analysis of Generic Substitution

  • Marilena Locatelli
  • Steinar Strøm


Using an extensive longitudinal dataset extracted from the Norwegian Prescription Database (NorPD), Norwegian title: Reseptregisteret, from the Norwegian Institute of Public Health (NIPH) containing all prescriptions written in the period May 2004 to June 2007, we selected two particular drugs (chemical substances) used against cholesterol. The two brand-name products on the Norwegian markets are Provachol (Anatomic Therapeutic Chemical (ATC) classification code C10AA03) and Zocor (ATC code C10AA01). The generics are Provastatine and Simastatine. We find that prices have a negative impact on transitions in the sense that an increase in the brand price will reduce the transition from generics to brand and likewise an increase in the generic price will reduce the transition from brand to generics. Moreover, we find that the older a male doctor is, the more likely it is that he continues to prescribe the brand-name product.


Generics Substitution Microdata Random utility model Longitudinal data 


C35 I 18 L 65 



We wish to acknowledge the services of the NorPD (and particularly of Kari Furu) in providing data. This research is supported by grants from the Norwegian Research Council. Financial support to M. Locatelli from The Frisch Centre, Oslo is gratefully acknowledged.


  1. Andreassen, L., Di Tommaso, M. L., & Strøm, S. (2013). Do medical doctors respond to economic incentives. Journal of Health Economics, 32, 392–409.CrossRefGoogle Scholar
  2. Dagsvik, J. K. (2002). Discrete choice in continuous time: implications of an intertemporal version of the IIA property. Econometrica, 70, 817–831.CrossRefGoogle Scholar
  3. Dalen, D. M., Locatelli, M., & Strøm, S. (2011). Generic substitution: micro evidence from register data in Norway. European Journal of Health Economics, 12(1), 49–59.CrossRefGoogle Scholar
  4. Furu, K. (2001). Drug utilisation in a public health perspective: establishing a national prescription register in Norway. Norwegian Journal of Epidemiology, 11(1), 55–60.Google Scholar
  5. Norwegian Institute of Public Health (NIPH), “Norwegian Prescription Database (NorPD)”, and
  6. Resnick, S., & Roy, R. (1990). Multivariate extremal processes, leader processes and dynamic choice models. Advances in Applied Probability, 22, 309–331.CrossRefGoogle Scholar
  7. Train, K. E. (2003). Discrete choice methods with simulations. Cambridge: Cambridge University Press.CrossRefGoogle Scholar

Copyright information

© International Atlantic Economic Society 2015

Authors and Affiliations

  1. 1.The Frisch CentreOsloNorway
  2. 2.Department of EconomicsUniversity of TurinTurinItaly

Personalised recommendations